Breast involvement is a rare event in SLE patients. The most frequent presentation is lupus panniculitis with skin erithema; tenderness, and parenchymal nodules. However, when breast masses are detected in SLE patients without significant superficial inflammation, it is mandatory to rule out breast carcinoma. Here, we report the case of a 47-year-old woman with an IS-year-Iong history of SLE, who presented with a suspicious breast mass. Since surgical trauma has been reported to be able to exacerbate breast inflammation in lupus mastitis, an ultrasound-guided minimally invasive Mammotome biopsy was performed to obtain tissue samples for histological and immunohistochemical examinations. Histology was consistent with lupus mastitis. The patient was already on mycophenolate mofetil and hydroxychloroquine. At the latest follow-up visit 6 years later, no progression of the breast lesion was observed.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by involvement of multiple organs and systems and by detection of autoantibodies towards several nuclear autoantigens. The natural history of SLE is highly heterogeneous and virtually all tissues and organs can be involved. However, even if the disease occurs more frequently in women, with a female to male ratio ranging from 8: 1 to 13:1, breast involvement is a rare event. Breast pathology in SLE patients frequently presents as lupus panniculitis with skin erythema, tenderness, pain, and parenchymal nodules (1-2). In some cases, lupus mastitis can herald SLE (3) .
Diagnostic difficulties arise when breast masses are detected without significant cutaneous inflammation indicative of lupus panniculitis; in these cases, it is mandatory to rule out breast carcinoma (4) (5) (6) . Furthermore, since in SLE patients surgical trauma can exacerbate breast inflammation, minimally invasive procedures should be carried out for diagnostic purposes (7) .
Here, we report the diagnostic procedures selected for a 47-year-old patient with a long history ofSLE, who presented with episodes of recurrent acute mastitis and a suspicious breast nodule, suggestive of cancer.
Case report
A 47-year-old woman, married with two children, was diagnosed with SLE because of malar rash, photosensitivity, leukopenia and anemia, non-erosive arthritis, depression, high titers of anti-nuclear (ANA) and anti-ds-DNA antibodies, recurrent fever, and fatigue. Laboratory tests also showed positivity for autoantibodies specific to 52kDa and 60kDa RolSSA antigens, but not to LaISSB , Sm, Sm/RNP, or Scl70 antigens. Search for antiphospholipid antibodies was persistently negative. Liver and kidney function tests were normal. For about 10 years, the patient had taken prednisolone at variable dosages, depending on severity of symptoms, hydroxychloroquine (200 mg b.i.d.), and fluoxetine (20 mg i.d.). Due to severe side effects of steroid therapy such as hypertension, fluid retention, and skin atrophy with easy occurrence of slowly healing wounds on the lower limbs after minor trauma, she was finally switched to mycophenolate mofetil (500 mg t.i.d.), while steroids were gradually tapered off. The patient showed significant clinical improvement. Two years later, the patient suffered from recurrent episodes of acute bilateral mastitis, successfully treated with antibiotics and anti-inflammatory drugs. At a follow-up visit one year later, a firm, painless mass with irregular margins was detected in the area between the upper and lower external quadrants of the right breast. Cutaneous erythema, secondary to photosensitivity, was present on the upper trunk, but the skin overlying the mass did not show signs of inflammation. Nipples were retracted bilaterally.
Diagnostic methods
To define the morphological features of the right breast nodule, breast ultrasonography and mammography were performed. Since cytological examination of a fine needle aspiration from the nodule was inconclusive, a minimally invasive surgical technique, namely Mammotome biopsy, (8-9) was performed. The procedure allowed retrieval of 10 tissue specimens, each about 20 mm long, from the nodule (Fig. I a, b) .
Tissue samples were fixed in 10% formalin with PBS. After dehydration and diaphanization, they were included in histovax resin. For histological examination, the 4-/-1 sections were mounted on glass slides, deparaffinized in 100% xylene, rehydrated through graded alcohol solutions, and stained with hematoxilin-eosin. Immunohistochemical stainings were performed on 4-/-1 sections included in histovax resin. The sections were mounted on charged polylisine-coated slides and processed by an automatic immunostainer (FBMK 750600, Ventana Medical System, Inc., Tucson, AZ, USA) . Monoclonal antibodies specific for CD3, CD4, CD8, CD20, CD68, interleukin-6 (IL-q), heavy chains of human IgG, IgM, IgA, complement C3, metallothionein, and p53 were used.
RESULTS
Ultrasonography showed a non-homogeneous area of parenchyma under the right breast areola (18 x 20 mm), which included an irregularly defined vascularized hypoechoic nodule (15 mm in diameter) ( Fig . 2) . Due to the high density of the mammary gland tissue, mammography was not informative ( Fig . 3 ai, a2 ).
Cytology of a fine needle aspiration sample obtained from the nodule showed slightly dysplastic ductal cells along with inflammatory cells, mainly macrophages with a foamy cytoplasm.
Histology revealed areas of necrosis within the adipose tissue, chronic granulomatous inflammation and mammary gland dysplasia with simple cysts, coated with flattened epithelial ductal cells. Cysts were surrounded by dense aggregates oflymphocytes and monocytes with rare plurinucleated giant cells. Areas of stromal fibrosis and hyaline degeneration were also detected, while vascular structures displayed a prominent basal membrane and increased thickness of the vessel wall. Adipose tissue was infiltrated by lymphocytes and monocytes.
Immunohistochemistry revealed prevalence of CD20-positive B lymphocytes (Fig. 3b ) and IgGsecreting plasma cells, with few scattered CD4or CD8-positive T lymphocytes. CD68-positive monocytes and macrophages were detected in areas of granulomatosus inflammation (Fig. 3c) , while abundant deposits of C3 were present at the level of vascular and epithelial basal membranes (Fig.  3d ). Lack of expression of metallothionein and p53 argued against malignant transformation.
Overall, findings were consistent with a diagnosis of lupus mastitis. Six years later, at the latest follow-up visit, no progression in the right breast nodule was observed.
DISCUSSION
Lupus mastitis, as a clinicopathologic entity in the context of SLE, occurs in approximately 3% of patients; to date, only a few cases have been reported in the literature. Lupus mastitis often presents as lupus panniculitis, characterized by inflammation of subcutaneous fat, lymphocytic periductal and/or peri lobular infiltrates and vasculitis (1, [9] [10] . Since most patients with lupus mastitis are adult women and the disease can manifest with single or multiple 
. Cranio-caudal (aJ) and latero-lateral (a2) mammography of the right breast showing a retracted nipple and high glandular density with significant architectural distortion. Immunohistochemical detection ofCD20-positive B lymphocytes in periductallymphocytic aggregates (b). Immunohistochemical detection ofCD68positive cells (monocyte-macrophage lineage) in areas of granulomatous inflammation (c). Immunohistochemical detection of complement C3 in vascular and epithelial basal membranes (d).
intramammary nodules, it is often mandatory to rule out malignancy. Indeed, a recent populationbased, case-control study has shown that breast cancer risk is reduced in women diagnosed with rheumatoid arthritis and is not associated with other systemic autoimmune rheumatic diseases such as SLE, Sjogren's syndrome, systemic sclerosis, and dermatomyositis. Furthermore, a reduced risk for estrogen receptor-negative breast carcinoma has been observed among women with SLE (12) .
Most of the published reports on lupus mastitis have particularly stressed imaging and pathological features of this peculiar and rare breast disease (10) (11) 13) , rather than clinical and immunopathological features. Diffuse, bilateral calcifications on mammography, mainly related to calcified foci of degenerated or necrotic fat tissue, and ultrasonographic findings of recurrent breast lumps support the diagnosis of lupus mastitis (14) (15) . In addition, evidence of necrosis in the adipose tissue and peri glandular or perivascular lymphocyte infiltrations contribute to substantiate the diagnosis (11, (16) (17) .
Lupus mastitis can resemble breast carcinoma (6), either inflammatory (18) or erysipelatoides (19) . In these cases, to rule out malignancy, histopathology is mandatory. However, lupus mastitis may be exacerbated by surgical trauma; therefore, needle core biopsy should be preferred to open excisional biopsy. Indeed, the latter procedure has been reported to trigger a very painful progression of lupus mastitis, eventually ending up in obligate mastectomy (7) . In our patient, a minimally invasive diagnostic procedure, namely ultrasound-guided Mammotome biopsy, was performed without any adverse event.
Steroids and antimalarial drugs are usually effective in treating lupus mastitis; cyclophosphamide and surgical resection are generally not required (20) (21) . Our patient was treated with a short course of anti-inflammatory drugs and remained well controlled with mycofenolate mofetil (1.5 g per day) and hydroxychloroquine (400 mg per day). However, therapy is empirical due to the paucity of cases reported to date and recommendations can not be generalized.
Inconclusion, lupus mastitis should be considered as a diagnostic option in case breast masses or lumps remain undetected in SLE patients. Ultrasonography and a minimally invasive diagnostic technique such as Mammotome biopsy should be preferred to more aggressive diagnostic procedures. Medical treatment with immunosuppressive and/or immunomodulatory drugs should be tried initially, while surgical resection of the breast must be avoided.
